December 26, 2017 / 9:33 AM / a month ago

BRIEF-Guangzhou Boji Medical & Biotechnological and Changzhou-based firm to transfer all rights of patent

Dec 26(Reuters) - Guangzhou Boji Medical & Biotechnological Co Ltd

* Says co and a Changzhou-based biotech firm plan to transfer all rights of a patent (No. ZL 201410401604.7), regarding novel 2-(2, 4, 5-subsituted aniline) pyrimidine derivatives and use, in mainland China to a Zhejiang-based pharmaceutical firm, for 90 million yuan in total

Source text in Chinese: goo.gl/1WPx64

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below